Alimera Sciences reported $2.17M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Aerie Pharmaceuticals AERI:US $ 3.74M 3.04M
Alimera Sciences ALIM:US $ 2.17M 0.49M
Bayer BAYN:GR € 5680M 504M
Insmed INSM:US $ 16.4M 4.2M
Novartis NOVN:VX SF 3749M 6M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M